James E. Chastain - Concepedia

Author

James E. Chastain

Alcon (United States)ORCID

Also Known As

Bermbach, J. E. JUN. CHASTAIN, J.E. Chastain, James Chastain, James E. Chastain

Publications

457

Citations

H-Index

Concepts

All Affiliations

Alcon (United States)University of Kansas Medical Center Novartis (Switzerland)Novartis (United States)

About

James E. Chastain is an author at Alcon (United States) specializing in medicine, glaucoma, and ophthalmology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	207
2	Engineering	1	1	16
3	Nursing	1	1	29
4	Public Health	1	1	29
5	Social Sciences	1	1	17

James E. Chastain

Publications

363

Citations

H-Index

Page 1

	Year	Citations
Intraocular distribution of melanin in human, monkey, rabbit, minipig and dog eyes Chandrasekar Durairaj, James E. Chastain, Uday B. Kompella Experimental Eye Research RetinaOphthalmologyExperimental OphthalmologyGlaucomaDermatology	2012	79
Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye James E. Chastain, Mark Sanders, Michael A. Curtis, Experimental Eye Research Ophthalmic SurgeryOcular DiseasePharmacotherapyRetinal TherapiesNepafenac Ophthalmic Suspensions	2015	50
Concentrations of Betaxolol in Ocular Tissues of Patients with Glaucoma and Normal Monkeys after 1 Month of Topical Ocular Administration G. Holló, Jess T. Whitson, Robert Faulkner, Investigative Ophthalmology & Visual Science	2005	47
Ranibizumab Population Pharmacokinetics and Free VEGF Pharmacodynamics in Preterm Infants With Retinopathy of Prematurity in the RAINBOW Trial Matthew Fidler, Brian W. Fleck, Andreas Stahl, Translational Vision Science & Technology	2020	43
Subjects, Data, and Videotapes Patricia Heacock, Elaine Souder, James E. Chastain Nursing Research Population Health SciencesPrimary CarePatricia HeacockVideo Content AnalysisPublic Health	1996	29
A Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovascular Age-Related Macular Degeneration Stephen Poor, Georges Weissgerber, Christopher M. Adams, American Journal of Ophthalmology	2022	19
Intraocular and systemic pharmacokinetics of brolucizumab (RTH258) in nonhuman primates Erik L. Nimz, Clinton W. Van't Land, Jaime A. Yáñez, Investigative Ophthalmology & Visual Science Ocular DiseaseOphthalmologyExperimental OphthalmologyMedicineImmunology	2016	18
<i>In Vitro</i> Transport and Partitioning of AL-4940, Active Metabolite of Angiostatic Agent Anecortave Acetate, in Ocular Tissues of the Posterior Segment Paul J. Missel, James E. Chastain, Ashim K. Mitra, Journal of Ocular Pharmacology and Therapeutics	2010	17
Attenuation of cerebral glucose use in kainic acid-treated rats by diazepam James E. Chastain, Fred Samson, Stanley R. Nelson, European Journal of Pharmacology Kainic Acid-treated RatsNeurophysiologyMedicineNeuropharmacologyNeuroprotection	1987	17
Regiointegrity of carbanions derived by selective metalations of dimethylpyridines and -quinolines Edwin M. Kaiser, William R. Thomas, Terry E. Synos, Journal of Organometallic Chemistry Chemical EngineeringEngineeringHeterocyclicOrganic ChemistryOrganometallic Catalysis	1981	16

Page 1